Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Life Science Instrumentation Market 2017 - Global Forecast to 2022 - Research and Markets

share with twitter share with LinkedIn share with facebook
share via e-mail
10/26/2017 | 03:12pm CEST

The "Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR), Application (Research, Clinical), End User (Pharma-Biotech Companies, Food & Beverage Industry, Hospitals) - Global Forecast to 2022" report has been added to Research and Markets' offering.

The Global Life Science Instrumentation Market is Expected to Reach USD 75.24 Billion By 2022 from USD 54.49 Million in 2017, at a CAGR of 6.7%.

Increasing spending on pharmaceutical R&D, growing food safety concerns, availability of public and private funding for life science research, and continuous technological advancements in analytical instruments are some of the key factors driving the growth of this market. However, the high cost of instruments and the dearth of skilled professionals are expected to restrain market growth to a certain extent.

While North America is expected to account for the largest share of the market in 2017, APAC is expected to register the highest growth rate during the forecast period (2017-2022). This is owing to the rising focus of key market players in emerging Asian countries; increasing crop research studies in Asia to feed its growing population; the growing pharmaceutical industry in India and China; the large biomedical industry in Singapore; and rising number of conferences, exhibitions, and meetings on analytical instruments across the region.

Market Dynamics


  • Increasing Spending On Pharmaceutical R&D
  • Growing Food Safety Concerns
  • Technological Advancements in Analytical Instruments
  • Increasing Public-Private Investments in Life Science Research


  • High Cost of Instruments
  • Dearth of Skilled Professionals


  • Growth Opportunities in Emerging Countries
  • Growing Demand for Analytical Instruments And Focus of Key Market Players On Emerging Countries
  • Growth of the Pharmaceutical And Biotechnology Industry
  • Rising Demand for Analytical Instruments in Proteomics
  • Growing Application Horizons of Analytical Instruments


  • Inadequate Infrastructure for Research in Emerging Countries

Company Profiles

  • Agilent Technologies, Inc.
  • Becton, Dickinson And Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • Eppendorf Ag
  • Ge Healthcare
  • Hitachi High-Technologies Corporation
  • Horiba Ltd.
  • Merck Kgaa
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • Shimadzu Corporation
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation

For more information about this report visit https://www.researchandmarkets.com/research/flt3fj/life_science

© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news "Companies"
02:55aBenchmark Botanics Inc. Announces Results of AGM and Appointment of Chief Executive Officer
02:54aOil prices edge up on surprise drawdown in U.S. crude stockpiles
02:53aIDP EDUCATION : Change of Director's Interest Notice Opens in a new Window
02:53aRBR : Alliance with Kuiper International
02:47aSEALINK TRAVEL : notes SA Government response to contract extension
02:47aHUON AQUACULTURE : HUO Media Release Farmer of the Year Opens in a new Window
02:44aTHEODORA ORINGHER : Law Firm Files Defamation Lawsuit on Behalf of Former Microsemi Senior Executives Against Microchip Technology, Inc., CEO Steven Sanghi and Senior Management
02:43aPERPETUAL : 2019 Q1 FUM Statement
02:39aNetflix record subscriber growth dispels Wall Street worries
02:38aNetflix record subscriber growth dispels Wall Street worries
Latest news "Companies"